Literature DB >> 10081515

Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients.

H Verbaan1, J Carlson, S Eriksson, A Larsson, R Liedholm, R Manthorpe, H Tabery, A Widell, S Lindgren.   

Abstract

OBJECTIVE: To analyse the frequency of some extrahepatic manifestations of chronic hepatitis C virus (HCV) infection in northern European patients, including a postulated association between HCV and primary Sjögren's syndrome (SS).
DESIGN: Cohort study.
SETTING: Department of Medicine, Malmö University Hospital, Sweden. PATIENTS: Twenty-one patients with HCV infection and 53 with primary SS (according to the Copenhagen criteria). MAIN OUTCOME MEASURES: Cryoglobulins were analysed in all patients, while patients with primary SS were investigated with regard to markers of HCV infection, and HCV patients with objective tests of SS (Schirmer-1 test, break-up time, van Bijsterveld score, sialometry, labial salivary gland biopsy) and antibodies against nuclear antigens, smooth muscle (SMA) and mitochondria (AMA). HCV antigens in small salivary glands from lower lip biopsies were detected by immunohistochemical analysis.
RESULTS: Only one of the SS patients had detectable cryoprecipitates, while another was HCV-positive. None of the 21 HCV patients had cryoprecipitates. A total of 14/21 (67%) patients with HCV infection had at least one abnormal objective test suggestive of xerostomia or keratoconjunctivitis sicca, while eight (38%) had objective evidence of both eye and salivary gland involvement. HCV antigens were not detected in affected glands. Only two patients had clinical symptoms of SS, and two fulfilled the Copenhagen criteria for SS. None of the HCV-positive patients had detectable antibodies against SS-A, SS-B, RNP, Jo-1, PCNA or Scl-70, and the frequency of ANA/SMA/AMA was low.
CONCLUSIONS: While involvement of salivary and lacrimal glands was common in Swedish patients with HCV infection, cryoglobulinaemia was not observed. The pathogenetic mechanism responsible for glandular inflammation appears to be different from that in primary SS. HCV infection does not seem to be an aetiological factor for primary SS in this population. These observations suggest that viral, genetic or possibly environmental factors may be responsible for the reported high frequencies of systemic complications associated with chronic hepatitis C infection in southern Europe.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081515     DOI: 10.1046/j.1365-2796.1999.00414.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  14 in total

1.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

2.  Sicca complex among Egyptian patients with chronic hepatitis C virus infection.

Authors:  Zeinab Nawito; Amr Amin; Sohier Abu El-Fadl; Khaled Abu El Einen
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

3.  Anti-ENA antibodies in patients with chronic hepatitis C virus infection.

Authors:  E D'Amico; C Palazzi; P Cacciatore; A Canelli; G Ursitti; L Cosentino; V Dogali; G Riario-Sforza; F Capani
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

4.  SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.

Authors:  O Billaut-Mulot; C Cocude; V Kolesnitchenko; M J Truong; E K Chan; E Hachula; X de la Tribonnière; A Capron; G M Bahr
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

Review 6.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 7.  Extrahepatic manifestations of hepatitis C virus.

Authors:  Richard K Sterling; S Bralow
Journal:  Curr Gastroenterol Rep       Date:  2006-02

Review 8.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

9.  Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.

Authors:  D Sène; P Ghillani-Dalbin; N Limal; V Thibault; T van Boekel; J-C Piette; P Cacoub
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

Review 10.  Oral manifestations of hepatitis C virus infection.

Authors:  Marco Carrozzo; Kara Scally
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.